文献速递肝胆胰外科胃肠外科

重新评估新辅助治疗后胰十二指肠切除术中术中颈部切缘修整对胰腺导管腺癌的作用:多中心分析

Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institutional Analysis.
PubMed 文献 · Ann Surg · 2024-05-06

该多中心分析纳入671例新辅助治疗后因常规胰腺导管腺癌行胰十二指肠切除术并术中颈部切缘冰冻切片分析的患者,比较完整整块切除、非整块完整切除和不完整切除三组的生存与复发,发现通过再切除将初始阳性颈部切缘转为非整块完整切除与不完整切除的总生存相当(26.9 vs 27.1个月,P=0.901),不能常规推荐。

要点

  • 在新辅助治疗后胰十二指肠切除术中,通过额外切除将初始阳性颈部切缘转为非整块完整切除,与不完整切除相比总生存相当(26.9 vs 27.1个月,P=0.901)。
  • 多变量分析中,颈部切缘状态与生存和复发无独立关联。
  • 作者结论认为,通过额外切除将初始阳性胰腺颈部切缘转换,在新辅助治疗后胰十二指肠切除术中无肿瘤学获益,不能常规推荐。

核心结论

  • 通过额外切除将初始阳性胰腺颈部切缘转换,在新辅助治疗后胰十二指肠切除术中无肿瘤学获益,不能常规推荐。

研究设计与样本

  • 多中心分析,纳入2013年至2019年在3家学术机构因常规胰腺导管腺癌行新辅助治疗后胰十二指肠切除术并术中颈部切缘冰冻切片分析的患者。

主要发现

  • 671例患者中,524例(78.1%)为完整整块切除,119例(17.7%)为非整块完整切除,28例(4.2%)为不完整切除。
  • 非整块完整切除和不完整切除的患者肿瘤更大、实体瘤疗效评价标准缓解率更低、更常需血管切除,且病理特征较完整整块切除更差。
  • 术后并发症发生率和接受辅助治疗的机会在各组间相当。
  • 完整整块切除与最长的总生存时间相关(34.3个月)。
  • 在颈部切缘阳性患者中,通过再切除获得非整块完整切除与不完整切除相比总生存相当(26.9 vs 27.1个月,P=0.901),无复发生存结果相似。

临床怎么用

  • 原文结论认为,通过额外切除将初始阳性胰腺颈部切缘转换,在新辅助治疗后胰十二指肠切除术中无肿瘤学获益,不能常规推荐。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To investigate whether revision of pancreatic neck margin based on intraoperative frozen section analysis has oncologic value in postneoadjuvant pancreatoduodenectomy (PD) for pancreatic ductal adenocarcinoma. BACKGROUND: The role of intraoperative neck margin revision has been controversial, with little information specific to postneoadjuvant PD. METHODS: Patients who underwent postneoadjuvant PD (2013-2019) for conventional pancreatic ductal adenocarcinoma with frozen section analysis of neck margin at 3 academic institutions were included. Overall survival (OS) and recurrence-free survival were compared across 3 groups: complete resection achieved en bloc (CR-EB), complete resection achieved non-en bloc (CR-NEB), and incomplete resection (IR). RESULTS: Among the 671 patients included, 524 (78.1%) underwent CR-EB, 119 (17.7%) CR-NEB and 28 (4.2%) IR. Patients undergoing CR-NEB and IR exhibited larger tumors and lower rates of "Response Evaluation Criteria in Solid Tumors" response, requiring vascular resections more often. Likewise, CR-NEB and IR were associated with a worse pathologic profile than CR-EB. The incidence of postoperative complications and access to adjuvant treatment were comparable among groups. A CR-EB was associated with the longest OS duration (34.3 months). In patients with positive neck margin, obtaining a CR-NEB through reexcision was associated with a comparable OS relative to patients with an IR (26.9 vs 27.1 months, P = 0.901). Similar results were observed for recurrence-free survival. At multivariable analysis, neck margin status was not independently associated with survival and recurrence. CONCLUSIONS: Conversion of an initially positive pancreatic neck margin by additional resection is not associated with oncologic benefits in postneoadjuvant PD and cannot be routinely recommended.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Malleo G, Lionetto G, Crippa S, et al. Reappraising the Role of Intraoperative Neck Margin Revision in Postneoadjuvant Pancreatoduodenectomy for Pancreatic Ductal Adenocarcinoma: A Multi-institutional Analysis. Ann Surg. 2024. PMID: 38708617. doi:10.1097/SLA.0000000000006322

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。